Levin Group announced that it has been engaged by Novalar Pharmaceuticals to develop a program to demonstrate to dental professionals the value of OraVerse as

The U.S. market for anesthesia, respiratory and sleep management devices will reach $4.1 billion by 2015, according to a new report series by iData Research.

Dear DrBicuspid Member, Do you have a favorite new product you think deserves recognition? Do your colleagues deserve special attention for their efforts in education

Encourage smokers to smoke. Put patients in wheelchairs, even if they can walk. And if they get really upset, administer peppermint LifeSavers. These were some

The mother of a 15-year-old boy who died from wearing a fentanyl patch prescribed after dental surgery is suing Seattle Children’s Hospital and the two

A Pennsylvania oral surgeon who was acquitted earlier this year of molesting 17 female patients under anesthesia has been sued by four of those women,

Promethazine (Phenadoz, Phenergan, Promethegan) can cause gangrene and should only be used in a deep intramuscular injection, according to a warning from the U.S. FDA.

The first lawsuit against Merck regarding the relationship between the drug Fosamax and the development of osteonecrosis of the jaw (ONJ) may have ended in

Troikaa Pharmaceuticals has introduced Xynova Endo, a lidocaine lozenge for customized endoscopy procedures. The product is useful for anesthetizing a patient’s oral cavity or mouth

A Texas man is suing Cephalon, alleging that the company’s Actiq fentanyl lollipops — prescribed as a painkiller for cancer patients — rotted his teeth,

The U.S. Patent and Trademark Office issued a notice of allowance to Milestone Scientific for the company’s patent application, Computer Controlled Drug Delivery System with

NEW YORK (Reuters), Sep 11 – A lawsuit alleging that Merck & Co.’s osteoporosis drug Fosamax caused jaw damage ended in a mistrial on Friday.